The Clinical Study Of The Therapy Of Yinchihujintang In Treating Midrange Or Seliare Jaundice Induced By Viral Hepatitis

Objective:The total bilirubin of midrange or seliare jaundice induced by viral hepatitis is up to more than 5 times. At present, this disease can be treated in chinese and western medicine. This study will analyse the patients' shi, re, du, states. And we will try to find out therapy of yinchihujintang maybe help the patients with midrange or seliare jaundice get well and reduce tbil.Method:60 patients were divided randomly to two groups named treated group and control group, the former group was composed of 30 cases and the latter 30 cases. Two groups of patients come form the outpatients of the first subsidiary hospital of Guangzhou University of Traditional Chinese Medicine. Both of the groups conform to the diagnosis standard of midrange or seliare jaundice induced by viral hepatitis. The treated group was treated with yinchihujintang therapy and western medicine,while the control group was treated in western medicine. Each patient was observed the changes both before and after treatment, such as clinical symptoms, physical signs, hepatic function indexes, and so on.Result:1. All chinical symptom and physical signs were improved in two groups(P< 0.05 or P<0.01). In the treated group, poor appetite, abdominal distension, dry and bitter taste, nauseating and hating oil, flank-pain and so on,were much better than the control group (p<0.05).2. The level of the serums ALT, AST,γ-GTdecreased significantly (P<0.05 or P <0.01). So there was efficiency on the treated group and the control group on ALT, AST,γ-GT. There was statistical significance between the treated group and the control group on ALT, AST(P<0.05).So the Yinchihujintang therapy was better than the western medicine therapy on ALT,AST.3. The therapy could decrease the level of tbil in the two groups. In the aspect of the treated group was decreased much more than the control (P<0.05).4. The therapy could reinforce total curative effect of treating the disease. the efficiency rate was 88.89%, and the excellence rate was 80.77 %.The curative effect was better than the control group (P>0.05)Conclousion:From the result, most patients of this disease, pathological change and pathogenesis,the differentiation of symptoms and signs fit the condition of tha. The therapy could inproved in the physical signs, tbil, AST, ALT and other hepatic function.